SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

OMXC 20 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Genmab: Click to view the issuer\'s details

Last update : 25/05/2014  >View issuer details

2021.05.10 | 09:55 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Transactions in connection with share buy-back program - HTML (w)

2021.05.05 | 17:01 | Periodic information / 1st Quarter Information

English version HTML (w) Mail

puce Genmab Announces Financial Results for the First Quarter of 2021 - HTML (w)

2021.05.03 | 09:47 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Transactions in connection with share buy-back program - HTML (w)

2021.04.26 | 09:18 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Transactions in connection with share buy-back program - HTML (w)

2021.04.20 | 12:34 | Periodic information / 1st Quarter Information

English version HTML (w) Mail

puce Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021 - HTML (w)

2021.04.19 | 09:51 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Transactions in connection with share buy-back program - HTML (w)

2021.04.13 | 15:26 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Passing of Genmab A/S’ Annual General Meeting - HTML (w)

2021.04.12 | 09:54 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Transactions in connection with share buy-back program - HTML (w)

2021.04.06 | 09:20 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Transactions in connection with share buy-back program - HTML (w)

2021.03.30 | 07:21 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 261